Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Foamix Pharmaceuticals Ltd. (FOMX)

Income Statement Business | Geographic

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K/A20-F
Revenues   [+]0.43.63.75.50.85.4
            Revenue growth  -87.7%-2.0%-33.6%551.0%-84.3% 
Cost of goods sold  0.00.00.00.10.10.5
Gross profit  0.43.63.75.50.84.9
            Gross margin  100.0%100.0%99.6%98.9%91.8%90.3%
Selling, general and administrative  45.114.011.59.27.03.0
Research and development  51.264.557.825.910.73.6
Other operating expenses       -3.3
EBITDA   [+]-95.5-74.6-65.4-29.5-16.81.7
            EBITDA margin  -21562.8%-2074.4%-1782.3%-533.9%-1983.9%30.8%
Depreciation and amortization  0.40.30.20.10.10.0
EBIT   [+]-95.9-74.9-65.6-29.7-16.91.6
            EBIT margin  -21641.8%-2083.2%-1788.3%-536.5%-1994.1%30.2%
Other income (expense), net  192.0148.8130.258.633.49.8
Pre-tax income  95.474.064.628.916.511.5
Income taxes  0.2-0.2-1.2-0.40.00.0
            Tax rate  0.2%     
Net income  95.274.265.729.316.511.5
            Net margin  21484.9%2062.9%1791.1%530.8%1945.5%212.1%
   
Basic EPS   [+]$1.66$1.70$1.76$0.91$0.59$0.79
Diluted EPS   [+]$1.66$1.70$1.76$0.91$0.59$0.79
   
Shares outstanding (basic)   [+]57.343.737.432.328.214.5
Shares outstanding (diluted)   [+]57.343.737.432.328.214.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy